Profiel
Karim Dabbagh is the founder of Modus Biomedicine, Inc. which was founded in 2009.
He held the title of Chief Executive Officer from 2009 to 2010.
Dr. Dabbagh is currently the Independent Chairman at Maat Pharma SA since 2023.
Previously, he worked at Second Genome, Inc. from 2014 to 2023, where he held the titles of President, Chief Executive Officer & Director from 2018 to 2023.
Dr. Dabbagh completed his undergraduate degree at Imperial College London and his doctorate at University College London.
Actieve functies van Karim Dabbagh
| Bedrijven | Functie | Begin |
|---|---|---|
| MAAT PHARMA | Voorzitter | 21-06-2023 |
Eerdere bekende functies van Karim Dabbagh
| Bedrijven | Functie | Einde |
|---|---|---|
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Algemeen Directeur | 01-09-2023 |
| Modus Biomedicine, Inc. | Algemeen Directeur | 01-12-2010 |
Opleiding van Karim Dabbagh
| University College London | Doctorate Degree |
| Imperial College London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MAAT PHARMA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
| Modus Biomedicine, Inc. |